Skip to main content

Table 6 Mean percent blood glucose reduction in normal rabbits (N = 6)

From: Influence of non-nucleoside reverse transcriptase inhibitors (efavirenz and nevirapine) on the pharmacodynamic activity of gliclazide in animal models

Time

(h)

Gliclazide

Nevirapine

Nevirapine + Gliclazide*(Single dose treatment)

Nevirapine + Gliclazide*(Multiple dose treatment)

1

19.44 ± 2.25

02.08 ± 2.38

21.09 ± 2.93

20.39 ± 2.00

2

26.73 ± 2.57

03.57 ± 2.48

25.38 ± 2.40

26.56 ± 0.90

3

36.18 ± 1.08

05.72 ± 2.23

34.38 ± 0.69

35.18 ± 1.39

4

28.90 ± 3.23

04.59 ± 2.66

26.48 ± 1.47

27.61 ± 1.83

6

24.62 ± 2.00

02.53 ± 1.89

23.21 ± 2.51

25.49 ± 1.05

8

19.13 ± 2.46

02.50 ± 1.42

18.59 ± 1.80

19.63 ± 2.79

12

14.46 ± 1.76

02.82 ± 2.51

12.87 ± 0.86

12.49 ± 1.91

16

08.23 ± 1.85

01.00 ± 2.29

06.36 ± 2.31

07.14 ± 0.99

20

04.99 ± 1.49

01.04 ± 1.54

03.92 ± 1.52

05.33 ± 1.18

24

02.14 ± 1.09

00.63 ± 1.94

01.37 ± 1.43

03.87 ± 1.91

  1. *Statistically no significance compared to gliclazide control